Department of Anesthesiology and Intensive Care, GRCB 48, IFR 150, Toulouse University Hospital, Toulouse, France.
Crit Care. 2011;15(1):R49. doi: 10.1186/cc10013. Epub 2011 Feb 3.
The aim of this study, performed in an intensive care unit (ICU) population with a normal serum creatinine, was to estimate urinary creatinine clearance (CLCR) in a population of polytrauma patients (PT) through a comparison with a population of non trauma patients (NPT).
This was a retrospective, observational study in a medical and surgical ICU in a university hospital. A total of 284 patients were consecutively included. Two different groups were studied: PT (n = 144) and NPT (n = 140). Within the second week after admission to the ICU, renal function was assessed using serum creatinine, 24 h urinary CLCR .
Among the 106 patients with a CLCR above 120 mL minute(-1) 1.73 m(-2), 79 were PT and 27 NPT (P < 0.0001). Only 63 patients had a CLCR below 60 mL minute(-1) 1.73 m(-2) with 15 PT and 48 NPT (P < 0.0001). Patients with CLCR greater than 120 mL minute(-1). 1.73 m(-2) were younger, had a lower SAPS II score and a higher male ratio as compared to those having CLCR lower than 120 mL minute(-1). 1.73 m(-2). Through a logistic regression analysis, age and trauma were the only factors independently correlated to CLCR.
In ICU patients with normal serum creatinine, CLCR, is higher in PT than in NPT. The measure of CLCR should be proposed as routine for PT patients in order to adjust dose regimen, especially for drugs with renal elimination.
本研究在血清肌酐正常的重症监护病房(ICU)人群中进行,旨在通过与非创伤患者(NPT)人群进行比较,估算多发伤患者(PT)的尿肌酐清除率(CLCR)。
这是一项在大学医院的内科和外科 ICU 进行的回顾性观察性研究。连续纳入了 284 名患者。研究了两组人群:PT(n=144)和 NPT(n=140)。在 ICU 住院后的第二周内,通过血清肌酐和 24 小时尿 CLCR 评估肾功能。
在 106 名 CLCR 大于 120 mL/min·1.73 m(-2)的患者中,79 名是 PT,27 名是 NPT(P<0.0001)。仅有 63 名患者的 CLCR 低于 60 mL/min·1.73 m(-2),其中 15 名是 PT,48 名是 NPT(P<0.0001)。CLCR 大于 120 mL/min·1.73 m(-2)的患者比 CLCR 小于 120 mL/min·1.73 m(-2)的患者年龄更小、SAPS II 评分更低、男性比例更高。通过逻辑回归分析,年龄和创伤是与 CLCR 唯一相关的独立因素。
在血清肌酐正常的 ICU 患者中,PT 的 CLCR 高于 NPT。对于 PT 患者,应建议常规测量 CLCR,以调整剂量方案,特别是对于具有肾脏清除的药物。